Because long-term reproductive studies remain limited, most providers recommend avoiding peptide therapy during: Patients attempting to conceive should discuss all medications, supplements, and peptide therapies with their healthcare provider
For autoimmune patients who benefit metabolically from tirzepatide, planning pregnancy requires coordinated timing between optimizing body weight and metabolic health, ensuring autoimmune disease is in remission or well-controlled, washing out tirzepatide with adequate lead time, and transitioning to pregnancy-safe autoimmune medications
Final Thoughts BPC-157 has generated significant interest in the wellness and regenerative space because of its potential to support healing, recovery, and overall resilience
IP teams should integrate post-LOE formulary defense strategy into biologic lifecycle planning at NDA/BLA submission, not at patent expiration
CJC-1295 NO DAC & IPAMORELIN BLEND (2mg each = 4mg total) Order in bulk and SAVE
